Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
361.14
-0.50 (-0.14%)
Nov 19, 2025, 10:43 AM EST - Market open
Cencora Employees
Cencora had 46,000 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
46,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,985,496
Profits / Employee
$33,786
Market Cap
70.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | 22,000 | 0 | - |
| Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
| Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
| Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
| Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
| Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
| Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
| Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
| Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
| Sep 30, 2011 | 10,300 | 300 | 3.00% |
| Sep 30, 2010 | 10,000 | -300 | -2.91% |
| Sep 30, 2009 | 10,300 | -600 | -5.50% |
| Sep 30, 2008 | 10,900 | -400 | -3.54% |
| Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
| Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
| Sep 30, 2005 | 13,400 | -700 | -4.96% |
| Sep 30, 2004 | 14,100 | -700 | -4.73% |
| Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
| Sep 30, 2002 | 13,700 | 0 | - |
| Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COR News
- 11 days ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 13 days ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters
- 14 days ago - Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - WSJ
- 14 days ago - Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network - Business Wire
- 14 days ago - Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results - Business Wire
- 17 days ago - ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November - Seeking Alpha
- 4 weeks ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire